1. Home
  2. GNFT vs STXS Comparison

GNFT vs STXS Comparison

Compare GNFT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • STXS
  • Stock Information
  • Founded
  • GNFT 1999
  • STXS 1990
  • Country
  • GNFT France
  • STXS United States
  • Employees
  • GNFT N/A
  • STXS N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GNFT Health Care
  • STXS Health Care
  • Exchange
  • GNFT Nasdaq
  • STXS Nasdaq
  • Market Cap
  • GNFT 179.7M
  • STXS N/A
  • IPO Year
  • GNFT 2019
  • STXS 2004
  • Fundamental
  • Price
  • GNFT $3.74
  • STXS $2.49
  • Analyst Decision
  • GNFT Strong Buy
  • STXS Strong Buy
  • Analyst Count
  • GNFT 1
  • STXS 2
  • Target Price
  • GNFT $13.00
  • STXS $4.50
  • AVG Volume (30 Days)
  • GNFT 9.9K
  • STXS 412.8K
  • Earning Date
  • GNFT 09-19-2024
  • STXS 03-03-2025
  • Dividend Yield
  • GNFT N/A
  • STXS N/A
  • EPS Growth
  • GNFT N/A
  • STXS N/A
  • EPS
  • GNFT 0.47
  • STXS N/A
  • Revenue
  • GNFT $86,225,222.00
  • STXS $25,143,000.00
  • Revenue This Year
  • GNFT $145.20
  • STXS $3.73
  • Revenue Next Year
  • GNFT N/A
  • STXS $54.27
  • P/E Ratio
  • GNFT $7.89
  • STXS N/A
  • Revenue Growth
  • GNFT 175.45
  • STXS N/A
  • 52 Week Low
  • GNFT $3.35
  • STXS $1.66
  • 52 Week High
  • GNFT $6.42
  • STXS $3.29
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 49.41
  • STXS 61.67
  • Support Level
  • GNFT $3.68
  • STXS $2.26
  • Resistance Level
  • GNFT $4.03
  • STXS $2.52
  • Average True Range (ATR)
  • GNFT 0.15
  • STXS 0.13
  • MACD
  • GNFT 0.05
  • STXS 0.03
  • Stochastic Oscillator
  • GNFT 57.35
  • STXS 89.80

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: